Quick answerHold methimazole and escalate
possible clinically significant hepatotoxicity.
Why this is correctThe label directs liver-function evaluation for anorexia, pruritus, or right-upper-quadrant pain and prompt discontinuation when clinically significant liver abnormality includes transaminases above 3 times normal.
Easy analogy or mental pictureWhen the organ-processing plant sounds an alarm, do not send another load through it.
Memory hookMethimazole plus RUQ symptoms and marked enzymes: hold and evaluate.NCLEX decision ruleUse symptom and laboratory thresholds together; do not normalize a trend that meets a labeled stop criterion.
Why the other choices are wrongFood, dose escalation, and delayed review do not address the injury mechanism.
References
1DailyMed: MethimazoleAgranulocytosis warning and prompt discontinuation for clinically significant liver abnormality